Ganciclovir Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-315

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ganciclovir (NDC 63323-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gan04 0000 01

FDA Label Image

Gan04 0000 02

This is a chemical formula for ganciclovir, which is a medication used to treat viral infections. The formula indicates the molecular composition of the drug, and also provides the molecular weight (M.W.) of the compound, which can be used in determining dosages and other pharmacological parameters.*

FDA Label Image

Gan04 0000 03

This text may represent a graph showing the progression of CMV retinitis over time, with the x-axis representing the number of days from the start of maintenance therapy and the y-axis representing the time to progression. However, this is not confirmed without further context or visuals.*

FDA Label Image

Gan04 0000 04

FDA Label Image

Gan04 0000 05

This text refers to a study or data analysis called AVI 034, which measures the time to progression of CMV retinitis. The numbers 30, 60, 920, and 120 relate to time in days from the start of maintenance therapy.*

FDA Label Image

Gan04 0000 06

FDA Label Image

Gan04 0000 07

FDA Label Image

Gan04 0000 08

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.